Selected research
Industry Research
Valbenazine API Industry Research Report 2026
Market perspective
The global Valbenazine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Valbenazine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Valbenazine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Valbenazine API include Zhejiang Hengtengfu Pharmaceutical, Shaanxi Dideu Medichem, Nantong HI-FUTURE Biology, Jiangxi LongLife Bio-pharmaceutical, Jiangsu Vcare PharmaTech, Chengdu Miracle Pharmaceutical, SynZeal Research, MSN Laboratories and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Valbenazine API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Valbenazine API Market by Company
Zhejiang Hengtengfu Pharmaceutical
Shaanxi Dideu Medichem
Nantong HI-FUTURE Biology
Jiangxi LongLife Bio-pharmaceutical
Jiangsu Vcare PharmaTech
Chengdu Miracle Pharmaceutical
SynZeal Research
MSN Laboratories
Lupin
Acharya Chemical
Valbenazine API Segment by Type
Purity ≥ 98%
Purity ≥ 99%
Valbenazine API Segment by Application
Online Sales
Offline Sales
Valbenazine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbenazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Valbenazine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Valbenazine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Valbenazine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98%
- Purity ≥ 99%
Applications
- Online Sales
- Offline Sales
Companies covered
- Zhejiang Hengtengfu Pharmaceutical
- Shaanxi Dideu Medichem
- Nantong HI-FUTURE Biology
- Jiangxi LongLife Bio-pharmaceutical
- Jiangsu Vcare PharmaTech
- Chengdu Miracle Pharmaceutical
- SynZeal Research
- MSN Laboratories
- Lupin
- Acharya Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Valbenazine API Market Size (2021-2032)
- 2.2.2 Global Valbenazine API Sales (2021-2032)
- 2.2.3 Global Valbenazine API Market Average Price (2021-2032)
- 2.3 Valbenazine API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity ≥ 98%
- 2.3.3 Purity ≥ 99%
- 2.4 Valbenazine API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Valbenazine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Valbenazine API Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Valbenazine API Revenue of Manufacturers (2021-2026)
- 3.4 Global Valbenazine API Average Price by Manufacturers (2021-2026)
- 3.5 Global Valbenazine API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Valbenazine API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Valbenazine API, Product Type & Application
- 3.8 Global Manufacturers of Valbenazine API, Established Date
- 3.9 Global Valbenazine API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Hengtengfu Pharmaceutical
- 4.1.1 Zhejiang Hengtengfu Pharmaceutical Company Information
- 4.1.2 Zhejiang Hengtengfu Pharmaceutical Business Overview
- 4.1.3 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio
- 4.1.5 Zhejiang Hengtengfu Pharmaceutical Recent Developments
- 4.2 Shaanxi Dideu Medichem
- 4.2.1 Shaanxi Dideu Medichem Company Information
- 4.2.2 Shaanxi Dideu Medichem Business Overview
- 4.2.3 Shaanxi Dideu Medichem Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shaanxi Dideu Medichem Valbenazine API Product Portfolio
- 4.2.5 Shaanxi Dideu Medichem Recent Developments
- 4.3 Nantong HI-FUTURE Biology
- 4.3.1 Nantong HI-FUTURE Biology Company Information
- 4.3.2 Nantong HI-FUTURE Biology Business Overview
- 4.3.3 Nantong HI-FUTURE Biology Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nantong HI-FUTURE Biology Valbenazine API Product Portfolio
- 4.3.5 Nantong HI-FUTURE Biology Recent Developments
- 4.4 Jiangxi LongLife Bio-pharmaceutical
- 4.4.1 Jiangxi LongLife Bio-pharmaceutical Company Information
- 4.4.2 Jiangxi LongLife Bio-pharmaceutical Business Overview
- 4.4.3 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio
- 4.4.5 Jiangxi LongLife Bio-pharmaceutical Recent Developments
- 4.5 Jiangsu Vcare PharmaTech
- 4.5.1 Jiangsu Vcare PharmaTech Company Information
- 4.5.2 Jiangsu Vcare PharmaTech Business Overview
- 4.5.3 Jiangsu Vcare PharmaTech Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio
- 4.5.5 Jiangsu Vcare PharmaTech Recent Developments
- 4.6 Chengdu Miracle Pharmaceutical
- 4.6.1 Chengdu Miracle Pharmaceutical Company Information
- 4.6.2 Chengdu Miracle Pharmaceutical Business Overview
- 4.6.3 Chengdu Miracle Pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio
- 4.6.5 Chengdu Miracle Pharmaceutical Recent Developments
- 4.7 SynZeal Research
- 4.7.1 SynZeal Research Company Information
- 4.7.2 SynZeal Research Business Overview
- 4.7.3 SynZeal Research Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SynZeal Research Valbenazine API Product Portfolio
- 4.7.5 SynZeal Research Recent Developments
- 4.8 MSN Laboratories
- 4.8.1 MSN Laboratories Company Information
- 4.8.2 MSN Laboratories Business Overview
- 4.8.3 MSN Laboratories Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MSN Laboratories Valbenazine API Product Portfolio
- 4.8.5 MSN Laboratories Recent Developments
- 4.9 Lupin
- 4.9.1 Lupin Company Information
- 4.9.2 Lupin Business Overview
- 4.9.3 Lupin Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lupin Valbenazine API Product Portfolio
- 4.9.5 Lupin Recent Developments
- 4.10 Acharya Chemical
- 4.10.1 Acharya Chemical Company Information
- 4.10.2 Acharya Chemical Business Overview
- 4.10.3 Acharya Chemical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Acharya Chemical Valbenazine API Product Portfolio
- 4.10.5 Acharya Chemical Recent Developments
5 Global Valbenazine API Market Scenario by Region
- 5.1 Global Valbenazine API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Valbenazine API Sales by Region: 2021-2032
- 5.2.1 Global Valbenazine API Sales by Region: 2021-2026
- 5.2.2 Global Valbenazine API Sales by Region: 2027-2032
- 5.3 Global Valbenazine API Revenue by Region: 2021-2032
- 5.3.1 Global Valbenazine API Revenue by Region: 2021-2026
- 5.3.2 Global Valbenazine API Revenue by Region: 2027-2032
- 5.4 North America Valbenazine API Market Facts & Figures by Country
- 5.4.1 North America Valbenazine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Valbenazine API Sales by Country (2021-2032)
- 5.4.3 North America Valbenazine API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Valbenazine API Market Facts & Figures by Country
- 5.5.1 Europe Valbenazine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Valbenazine API Sales by Country (2021-2032)
- 5.5.3 Europe Valbenazine API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Valbenazine API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Valbenazine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Valbenazine API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Valbenazine API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Valbenazine API Market Facts & Figures by Country
- 5.7.1 South America Valbenazine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Valbenazine API Sales by Country (2021-2032)
- 5.7.3 South America Valbenazine API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Valbenazine API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Valbenazine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Valbenazine API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Valbenazine API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Valbenazine API Sales by Type (2021-2032)
- 6.1.1 Global Valbenazine API Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Valbenazine API Sales Market Share by Type (2021-2032)
- 6.2 Global Valbenazine API Revenue by Type (2021-2032)
- 6.2.1 Global Valbenazine API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Valbenazine API Revenue Market Share by Type (2021-2032)
- 6.3 Global Valbenazine API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Valbenazine API Sales by Application (2021-2032)
- 7.1.1 Global Valbenazine API Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Valbenazine API Sales Market Share by Application (2021-2032)
- 7.2 Global Valbenazine API Revenue by Application (2021-2032)
- 7.2.1 Global Valbenazine API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Valbenazine API Revenue Market Share by Application (2021-2032)
- 7.3 Global Valbenazine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Valbenazine API Value Chain Analysis
- 8.1.1 Valbenazine API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Valbenazine API Production Mode & Process
- 8.2 Valbenazine API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Valbenazine API Distributors
- 8.2.3 Valbenazine API Customers
9 Global Valbenazine API Analyzing Market Dynamics
- 9.1 Valbenazine API Industry Trends
- 9.2 Valbenazine API Industry Drivers
- 9.3 Valbenazine API Industry Opportunities and Challenges
- 9.4 Valbenazine API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst